As the 2025 bull market picks up steam, all eyes are on Lightchain AI, an emerging leader in the crypto space. Combining the ...

Lightchain AI is rapidly gaining ground as one of the most talked-about projects heading into 2025. With its presale already ...

Amid the current fear and volatility in the cryptocurrency market, Lightchain AI is making waves with its impressive presale ...

As Polygon (MATIC) continues to draw investor attention with its fast, low-cost blockchain infrastructure, its growing ...

Holders of Dogecoin, FLOKI, and Ripple (XRP) are beginning to shift their attention toward a rising star that’s generating ...

Meme coins such as Shiba Inu (SHIB) and Dogecoin (DOGE) have captured the attention of the crypto community, drawing millions ...

Oral presentation at ASCO to highlight topline Phase 2 data of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP ...

Partnership leverages AbTherx’s Atlas™ Binary Fixed Light Chain Mouse to accelerate Rondo’s pipeline of bispecific antibodies MOUNTAIN VIEW, CA / ACCESS Newswire / April 23, 2025 / AbTherx, Inc., a ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...